Browse articles from EyeWorld.org on the topic of the cornea. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Clara Chan, MD, Cornea editor, discussed the topics covered in this section.
With neurotrophic keratitis (NK), there is a lot to consider in terms of staging, making a diagnosis, and treatment. Three experts shared how they work up NK patients and some of options for handling these cases.
The COVID-19 pandemic has had an impact on the screening and use of corneal donor tissue for corneal transplants. Three surgeons spoke about the evolving regulations, tissue eligible for use, and more.
Sunday programming at the ASCRS Annual Meeting featured a general session and various symposia.
➤ Combination pharmaceutical therapy being investigated for presbyopia meets study endpoints ➤ Positive results in Phase 2 clinical trial for IOP-lowering agent ➤ Phase 3 results from study of gene therapy for retinal neurodegenerative diseases ➤ Positive safety results in Phase 1 anti-VEGF treatment ➤ ASCRS news and events
ASCRS Subspecialty Day will take place on Friday, July 23, and will include the ASCRS Refractive Day, ASCRS Cornea Day, and ASCRS Glaucoma Day programs. The chairs of these programs spoke to EyeWorld about what attendees can expect.
Clara Chan, MD, Cornea editor, shared an experience that emphasizes the value patient history can have on a diagnosis, in this case recurrent subconjunctival hemorrhages from conjunctivochalasis, which is the focus of an article in the section, as well as other issue highlights.
While in recent months mask use has been relaxed somewhat as health guidelines are updated to reflect increased vaccination status and declining case numbers, there are situations where mask wear continues. These have been credited with playing a role in saving lives, but they have been associated with some unintended ocular consequences as well.
Underdiagnosed, often neglected, and much more common than clinicians realize is how some physicians describe conjunctivochalasis. This article is a deep dive into the condition, its diagnosis, and management options.
Numerous studies have looked at different approaches to using bevacizumab and other anti-VEGF agents for anterior segment surgery. Several experts discussed their use and study of bevacizumab, particularly relating to corneal neovascularization and in corneal transplants.